Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and DNp73 isoforms through ubiquitin ligase PIR2

Apoptosis

Volumn 17, Issue 8, 2012, Pages 762-776

  Taebunpakul, P ^a,b   Sayan, B S ^c   Flinterman, M ^a,d   Klanrit, P ^e   Gaken J ^f   Odell, E W ^a   Melino, G ^g   Tavassoli, M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^e KHON KAEN UNIVERSITY   (Thailand)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptin; P73; PIR2; PUMA; RNF144B; Ubiquitin ligase E3

Indexed keywords

APOPTIN; PROTEIN P53; PROTEIN P73; PUMA PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE PIR2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GYROVIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RING FINGER MOTIF;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CAPSID PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; G2 PHASE CELL CYCLE CHECKPOINTS; HALF-LIFE; HUMANS; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

CHICKEN ANEMIA VIRUS;

EID: 84865152602     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0720-7     Document Type: Article

References (57)

1. Noteborn MH, de Boer GF, van Roozelaar DJ et al (1991) Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 65:3131-3139
2. Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F, Tavassoli M (2004) TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23:1153-1165 (Pubitemid 38269969)
3. Van Danen Oorschot AA, Fischer DF, Grimbergen JM et al (1997) Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 94:5843-5847 (Pubitemid 27241859)
4. Zhang YH, Leliveld SR, Kooistra K et al (2003) Recombinant apoptin multimers kill tumor cells but are nontoxic and epitopeshielded in a normal-cell-specific fashion. Exp Cell Res 289:36-46 (Pubitemid 36993835)
5. Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, Noteborn MH (1995) Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 55:486-489
6. Backendorf C, Visser AE, de Boer AG et al (2008) Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol 48:143-169 (Pubitemid 351756360)
7. Danen-van Oorschot AA, van Der Eb AJ, Noteborn MH (2000) The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol 74:7072-7078 (Pubitemid 30470691)
8. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M (2005) Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 118:4485-4493 (Pubitemid 41556346)
9. Tavassoli M, Guelen L, Luxon BA, Gaken J (2005) Apoptin: specific killer of tumor cells? Apoptosis 10:717-724 (Pubitemid 41187071)
10. Maddika S, Panigrahi S, Wiechec E et al (2009) Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Mol Cell Biol 29:1235-1248
11. Jiang J, Cole D, Westwood N et al (2010) Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin. Cancer Res 70:7242-7252
12. Danen-van Oorschot AA, den Hollander AI, Takayama S, Reed JC, van der Eb AJ, Noteborn MH (1997) BAG-1 inhibits p53-induced but not apoptin-induced apoptosis. Apoptosis 2:395-402 (Pubitemid 127504723)
13. Schoop RA, Kooistra K, Baatenburg De Jong RJ, Noteborn MH (2004) Bcl-xL inhibits p53-but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Int J Cancer 109:38-42 (Pubitemid 38160659)
14. Kaghad M, Bonnet H, Yang A et al (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819 (Pubitemid 27357971)
15. Muller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, Schilling T (2006) One, two, three-p53, p63, p73 and chemosensitivity. Drug Resist Updat 9:288-306
16. Melino G, De Laurenzi V, Vousden KH (2002) p73: friend or foe in tumorigenesis. Nat Rev Cancer 2:605-615 (Pubitemid 37328927)
17. Jost CA, Marin MC, Kaelin WG Jr (1997) p73 Is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389:191-194 (Pubitemid 27400602)
18. Zhu J, Jiang J, Zhou W, Chen X (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58:5061-5065 (Pubitemid 28521161)
19. Rossi M, Sayan AE, Terrinoni A, Melino G, Knight RA (2004) Mechanism of induction of apoptosis by p73 and its relevance to neuroblastoma biology. Ann NY Acad Sci 1028:143-149 (Pubitemid 40361818)
20. Grob TJ, Novak U, Maisse C et al (2001) Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8:1213-1223 (Pubitemid 34048476)
21. Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371-386 (Pubitemid 39031071)
22. Yang HW, Piao HY, Chen YZ et al (2000) The p73 gene is less involved in the development but involved in the progression of neuroblastoma. Int J Mol Med 5:379-384
23. Cai YC, Yang GY, Nie Y et al (2000) Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 21:683-689 (Pubitemid 30214025)
24. Stoffel A, Filippa D, Rao PH (2004) The p73 locus is commonly deleted in non-Hodgkin's lymphomas. Leuk Res 28:1341-1345 (Pubitemid 39314414)
25. Tomkova K, Belkhiri A, El-Rifai W, Zaika AI (2004) p73 Isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res 64:6390-6393 (Pubitemid 39297891)
26. Muller M, Schilling T, Sayan AE et al (2005) TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 12:1564-1577 (Pubitemid 41679162)
27. Casciano I, Mazzocco K, Boni L et al (2002) Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 9:246-251 (Pubitemid 34223868)
28. Zaika AI, Slade N, Erster SH et al (2002) DeltaNp73, a dominantnegative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196:765-780
29. Concin N, Hofstetter G, Berger A et al (2005) Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Clin Cancer Res 11:8372-8383 (Pubitemid 41746950)
30. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr (2003) Chemosensitivity linked to p73 function. Cancer Cell 3:403-410 (Pubitemid 38340308)
31. Ozaki T, Nakagawara A (2005) p73, A sophisticated p53 family member in the cancer world. Cancer Sci 96:729-737 (Pubitemid 43019823)
32. Oberst A, Rossi M, Salomoni P et al (2005) Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun 331:707-712 (Pubitemid 40615501)
33. Sayan BS, Yang AL, Conforti F et al (2010) Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci USA 107:12877-12882
34. Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G (2009) The F-box protein FBXO45 promotes the proteasomedependent degradation of p73. Oncogene 28:3157-3166
35. Rossi M, De Laurenzi V, Munarriz E et al (2005) The ubiquitinprotein ligase Itch regulates p73 stability. EMBO J 24:836-848 (Pubitemid 40396112)
36. Nyman U, Vlachos P, Cascante A, Hermanson O, Zhivotovsky B, Joseph B (2009) Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain. Mol Cell Biol 29:1814-1825
37. Ren J, Datta R, Shioya H et al (2002) p73beta Is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 277:33758-33765
38. Tsai KK, Yuan ZM (2003) c-Abl stabilizes p73 by a phosphorylation- augmented interaction. Cancer Res 63:3418-3424 (Pubitemid 36735903)
39. Villunger A, Michalak EM, Coultas L et al (2003) p53-and druginduced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036-1038 (Pubitemid 37386194)
40. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931-1936 (Pubitemid 36254551)
41. Ming L, Sakaida T, Yue W, Jha A, Zhang L, Yu J (2008) Sp1 and p73 activate PUMA following serum starvation. Carcinogenesis 29:1878-1884
42. Melino G, Bernassola F, Ranalli M et al (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083 (Pubitemid 38294697)
43. Klanrit P, Flinterman MB, Odell EW et al (2008) Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle 7:205-215 (Pubitemid 351366521)
44. Rohn JL, Zhang YH, Leliveld SR, Danen-van Oorschot AA, Henriquez NV, Abrahams JP, Noteborn MHM (2005) Relevance of apoptin's integrity for its functional behavior. J Virol 79:1337-1338 (Pubitemid 40053917)
45. Poon IK, Oro C, Dias MM, Zhang J, Jans DA (2005) Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res 65:7059-7064 (Pubitemid 41161232)
46. Lee YH, Cheng CM, Chang YF, Wang TY, Yuo CY (2007) Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Biochem Biophys Res Commun 354:391-395
47. Liu X, Zeidan YH, Elojeimy S et al (2006) Involvement of sphingolipids in apoptin-induced cell killing. Mol Ther 14:627-636 (Pubitemid 44480757)
48. Gong JG, Costanzo A, Yang HQ et al (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809 (Pubitemid 29293179)
49. Toh WH, Siddique MM, Boominathan L, Lin KW, Sabapathy K (2004) c-Jun regulates the stability and activity of the p53 homologue, p73. J Biol Chem 279:44713-44722 (Pubitemid 39430881)
50. Klanrit P, Taebunpakul P, Flinterman MB et al (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. Oncogene 28:3499-3512
51. Flinterman M, Gäken J, Farzaneh F, Tavassoli M (2003) E1Amediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines. Oncogene 22:1965-1977 (Pubitemid 36523634)
52. Di Como CJ, Gaiddon C, Prives C (1999) p73 Function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol 19:1438-1449 (Pubitemid 29046885)
53. Fricker M, O'Prey J, Tolkovsky AM, Ryan KM (2010) Phosphorylation of puma modulates its apoptotic function by regulating protein stability. Cell Death Dis 1:e59
54. Kucharski TJ, Gamache I, Gjoerup O, Teodoro JG (2011) DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein apoptin. J Virol 85:12638-12649
55. Yoshida K, Ozaki T, Furuya K et al (2008) ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin. Oncogene 27:1183-1188 (Pubitemid 351253185)
56. Hamilton G, Yee KS, Scrace S, O'Neill E (2009) ATM regulates a RASSF1A-dependent DNA damage response. Curr Biol 19:2020-2025
57. Sayan AE, Paradisi A, Vojtesek B, Knight RA, Melino G, Candi E (2005) New antibodies recognizing p73: comparison with commercial antibodies. Biochem Biophys Res Commun 330:186-193 (Pubitemid 40394951)